Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Applied Biologics completes GMP manufacturing of initial clinical lots of BIOxHEAL™, its lead investigational biologic.
-
Engineering AI startup, P-1 AI, Announces Its Series A Financing Led by NEA, Adding Jeff Immelt to the Company’s Board
-
WASHINGTON, July 29, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of e-discovery expert Diane Quick as a Senior Managing Director within the Technology...
-
Rhode Island, July 29, 2026 (GLOBE NEWSWIRE) -- The nonprofit Association of Migraine Disorders' global Shades For Migraine campaign achieved record participation in 2026 — reaching millions,...
-
SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following...
-
Applied Biologics expands national commercial payer engagement strategy for XWRAP® to broaden patient access.
-
Applied Biologics extends longstanding system-wide agreement with Providence Health & Services for XWRAP®.
-
– Response rates up to 50% across evaluated dose levels and median PFS of 13 months observed in pre-treated, cabozantinib-naïve, locally advanced or metastatic ccRCC patients – – Activity compares...
-
WASHINGTON, July 21, 2026 (GLOBE NEWSWIRE) -- The Coalition to Improve Access to Cancer Care (CIACC), convened by the International Myeloma Foundation (IMF), applauds Senators Tina Smith (D-MN) and...
-
Applied Biologics initiates multi-center real-world outcomes study of XWRAP® across chronic wound types.